...
首页> 外文期刊>Retina Today >Retina Today - Post-Game Film Review With the Wills Retina Coaches: Submacular Hemorrhage (May/June 2015)
【24h】

Retina Today - Post-Game Film Review With the Wills Retina Coaches: Submacular Hemorrhage (May/June 2015)

机译:今日视网膜-配戴威尔士视网膜教练的赛后电影评论:黄斑下出血(2015年5月/ 6月)

获取原文
           

摘要

In a previous installment of this column, we gave readers a glimpse into the inner workings of the monthly surgical conferences held by the senior retina fellows at Wills Eye Hospital (see “Post-Game Film Review With the Wills Retina Coaches: PVR and Retinal Detachment” on page 22 of the January/February 2015 issue of Retina Today). Due to the positive feedback, we decided to continue the post-game film review series. Joining us for this session to discuss the management of submacular hemorrhage are Allen Chiang, MD; Allen Ho, MD; Jason Hsu, MD; Richard Kaiser, MD; Joseph Maguire, MD; and Arunan Sivalingam, MD. Links to the videos are provided for readers to follow along. —S. K. Steve Houston III, MD; Ehsan Rahimy, MD; and David C. Reed, MD SUBMACULAR HEMORRHAGE AND ANTICOAGULANT USE This case involves an 85-year-old man with acute-onset loss of visual acuity in his left eye, down to 20/200 (Figure 1). At the time of the examination, he was taking apixaban (Eliquis, Bristol-Myers Squibb), a relatively new agent in the class of novel anticoagulants (NOACs), for atrial fibrillation. Preoperative Management Joseph Maguire, MD: When I see an extensive bleed such as the one in this case, I think of three potential scenarios: polypoidal choroidal vasculopathy, a retinal angiomatous proliferation (RAP) lesion, a patient on anticoagulation, or some combination of these. One often sees small hemorrhages with age-related macular degeneration (AMD), but large hemorrhages are less common. Ehsan Rahimy, MD: Do you routinely ask about anticoagulant use with your AMD patients? Dr. Maguire: You should look at your review of systems and what medications the patient is taking. Allen Ho, MD: If I see a large hemorrhage such as this in the setting of AMD, I assume there is an underlying tear of the retinal pigment epithelium (RPE), unless the differential diagnosis leads me elsewhere (eg, a macroaneurysm). Optical coherence tomography (OCT) can be helpful in confirming this. Figure 1. Preoperative color fundus (A), fluorescein angiography (B), and spectral-domain OCT (C) imaging of a patient presenting with acute-onset vision loss in the left eye secondary to submacular hemorrhage. Dr. Rahimy: Given the imaging findings, how would you manage this case? Would you consider an in-office pneumatic displacement, or would you go straight to the OR? Arunan Sivalingam, MD: You can tell from the OCT that the hemorrhage is mostly subretinal without much under the RPE, so this patient is a good candidate for surgical evacuation. Dr. Ho: This is an 85-year-old man who might not be a good candidate for surgery because of other systemic comorbidities. I am fine with trying a pneumatic displacement in the office, but for the larger bleeds I would prefer to do a surgical displacement because I feel I can clear the macula of hemorrhage more effectively. In thinner hemorrhages, though, I would advise against surgery and try an anti-VEGF injection. Richard Kaiser, MD: In terms of management, OCT is helpful. First, I like to see if the central retinal thickness has at least doubled when deciding whether or not to operate. This is because a thin hemorrhage may look ominous on examination but not necessarily respond well to surgery. Second, looking at the layers where the hemorrhage is located is useful. If the bleeding is 100% under the RPE, then the odds of actually helping this patient surgically are much lower, whereas, in this particular case, you can clearly see most of the bleeding exists between the retina and the RPE. Dr. Maguire: I often use OCT to estimate where to enter the subretinal space during surgery. The safest place to inject tissue plasminogen activator (tPA) under the retina is usually the area with the thickest blood. You do not want to enter under the RPE. Dr. Rahimy: How soon do you add this case to your operating schedule? Jason Hsu, MD: The sooner the better. If you
机译:在本专栏的前一部分中,我们向读者介绍了威尔斯眼科医院高级视网膜研究员每月举行的外科手术会议的内部工作情况(请参阅“威尔斯视网膜教练的赛后电影评论:PVR和视网膜脱离) ”(《今日视网膜》 2015年1月/ 2月号第22页)。由于得到了积极的反馈,我们决定继续进行赛后电影评论系列。医学博士Allen Chiang参加了本次会议,讨论黄斑下出血的治疗方法;医学博士何鸿Ho;医学博士徐son医学博士理查德·凯泽(Richard Kaiser);医学博士约瑟夫·马奎尔(Joseph Maguire);和医学博士Arunan Sivalingam。提供了视频链接,供读者继续阅读。 —S。马里兰州史蒂夫·休斯顿三世医学博士埃桑·拉希米(Ehsan Rahimy);以及戴维·C·里德(David C. Reed),医学博士蛛网膜下腔出血和抗肿瘤药的使用本案涉及一名85岁的男性,其左眼的急性发作视力下降至20/200(图1)。在检查时,他正在服用apixaban(Eliquis,Bristol-Myers Squibb),它是新型抗凝剂(NOACs)中相对较新的药物,用于房颤。术前管理Joseph Maguire,医学博士:当我看到这种情况下的广泛出血时,我想到了三种潜在的情况:息肉样脉络膜脉管炎,视网膜血管瘤增生(RAP)病变,抗凝治疗的患者或以下几种组合这些。人们经常看到与年龄相关的黄斑变性(AMD)引起的小出血,但大出血的情况则不太常见。医学博士埃桑·拉希米(Ehsan Rahimy):您是否经常询问AMD患者使用抗凝药的情况? Maguire博士:您应该查看系统检查以及患者正在服用的药物。医学博士Allen Ho:如果我在AMD的环境中看到这样的大出血,我认为视网膜色素上皮(RPE)有潜在的撕裂,除非鉴别诊断将我引到其他地方(例如,大动脉瘤)。光学相干断层扫描(OCT)有助于确认这一点。图1.一名患者的术前彩色眼底(A),荧光素血管造影(B)和光谱域OCT(C)成像,其表现为继发于黄斑下出血的左眼急性发作视力丧失。 Rahimy博士:鉴于影像学发现,您将如何处理此病例?您会考虑在办公室内进行气动排量,还是直接去手术室?医学博士Arunan Sivalingam:您可以从OCT得知,出血大部分是视网膜下的,而在RPE下没有太多出血,因此该患者很适合进行手术疏散。何医生:这是一个85岁的男人,由于其他全身性合并症,可能不适合手术。我可以尝试在办公室进行气动置换,但对于较大的出血,我宁愿进行手术置换,因为我觉得我可以更有效地清除黄斑出血。但是,在较薄的出血中,我建议您不要手术,并尝试抗VEGF注射。医学博士Richard Kaiser:就管理而言,OCT是有帮助的。首先,我想看看在决定是否手术时,中央视网膜厚度是否至少增加了一倍。这是因为少量出血在检查时看起来可能是不祥的,但不一定对手术反应良好。其次,查看出血所在的层非常有用。如果在RPE下出血率为100%,那么实际通过手术帮助该患者的几率要低得多,而在这种情况下,您可以清楚地看到大部分出血都存在于视网膜和RPE之间。 Maguire博士:我经常使用OCT估计手术期间进入视网膜下腔的位置。在视网膜下注射组织纤溶酶原激活剂(tPA)的最安全的地方通常是血液最稠密的区域。您不想在RPE下输入。 Rahimy博士:您要多久将此案例添加到您的运营计划中?医学博士Jason Hsu:越早越好。如果你

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号